ClinicalTrials.gov
public full text
Public Domain
E4/DRSP Ovarian Function Inhibition Study
A combined oral contraceptive (COC) containing 15 mg E4 and 3 mg DRSP administered for 24 days followed by 4 placebo tablets, is being evaluated for further development. This study will investigate the effect of this COC on ovarian function inhibition, levels of serum luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol (E2) and progesterone during 3 treatment cycles in comparison with the reference COC 20 mcg EE/3 mg DRSP.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- BMI Effect on the Response to Ovulation Induction in Letrozole vs Clomid#1010047
- Piroxicam and Levonorgestrel Co-treatment for Emergency Contraception#909491
- INFERTILIDADE SAZONAL EM SUÍNOS: O QUE SABEMOS E COMO MINIMIZAR OS PROBLEMAS#96853
- Letrozole Extended vs Traditional Therapy for Ovulation Induction in Women With PCOS (PROLEx-PCOS)#850492
- Vaginal Estrogen for Improvement of Outcomes Following Pelvic Organ Prolapse Surgery#838076
Record · ID 839323
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive